Marc N Gourevitch

Biosketch / Results /

Marc Gourevitch

Muriel G. and George W. Singer Professor of Population Health, Department of Population Health
Professor, Department of Medicine
Professor, Department of Psychiatry

Chair of the Department of Population Health

Contact Info

Address
227 East 30th Street
New York, NY 10016

212/263-8553
Marc.Gourevitch@nyumc.org

Education

1987 — Harvard Medical School, M.D., Medical Education
1987-1988 — NYU Medical Center / Bellevue Hospital, Internship
1988-1990 — NYU Medical Center / Bellevue Hospital, Residency Training

Research Interests

Dr. Gourevitch's research interests center on health service utilization, medication adherence, and clinical epidemiology among drug users and other underserved populations; pharmacologic treatments for opioid dependence; and effective strategies for fostering behavior change among patients and clinicians. After an earlier focus on the clinical manifestations and response to treatment of syphilis and tuberculosis infection among drug users with and without HIV infection, Dr. Gourevitch's research has concentrated on the broad theme of how most effectively to meet drug users' diverse and complex needs for medical care. In addition, he is Principal Investigator on a CDC-funded training grant to prepare physicians for research careers at the interface of medicine and public health.

Saret: Evaluation of early career impact of interprofessional substance use research training
Bereket, S; Gourevitch, M N; Hanley, K; More, F; Naegle, M; Tuchman, E. Saret: Evaluation of early career impact of interprofessional substance use research training [Meeting Abstract]. Journal of general internal medicine. 2016 May 2016;31(2):S393-S393 (2150702)

EXTENDED-RELEASE NALTREXONE VERSUS ORAL NALTREXONE FOR ALCOHOL USE DISORDER TREATMENT IN PRIMARY CARE
Chen, J; Obi, R; Wong, S; Flannery, M; McDonald, R; Tofighi, B; Kermack, A; Laska, E; Rotrosen, J; Gourevitch, MN. EXTENDED-RELEASE NALTREXONE VERSUS ORAL NALTREXONE FOR ALCOHOL USE DISORDER TREATMENT IN PRIMARY CARE [Meeting Abstract]. Alcoholism: clinical & experimental research. 2016 JUN;40:233A-233A (2219942)

Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients
Kumar, Pritika C; Cleland, Charles M; Gourevitch, Marc N; Rotrosen, John; Strauss, Shiela; Russell, Linnea; McNeely, Jennifer. Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients. Drug & alcohol dependence. 2016 Jun 22;165:38-44 (2167262)

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders
Lee, Joshua D; Friedmann, Peter D; Kinlock, Timothy W; Nunes, Edward V; Boney, Tamara Y; Hoskinson, Randall A Jr; Wilson, Donna; McDonald, Ryan; Rotrosen, John; Gourevitch, Marc N; Gordon, Michael; Fishman, Marc; Chen, Donna T; Bonnie, Richard J; Cornish, James W; Murphy, Sean M; O'Brien, Charles P. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. New England journal of medicine. 2016 Mar;374(13):1232-1242 (2079662)

Extended-release naltrexone opioid treatment at jail re-entry (XOR)
McDonald, Ryan D; Tofighi, Babak; Laska, Eugene; Goldfeld, Keith; Bonilla, Wanda; Flannery, Mara; Santana-Correa, Nadina; Johnson, Christopher W; Leibowitz, Neil; Rotrosen, John; Gourevitch, Marc N; Lee, Joshua D. Extended-release naltrexone opioid treatment at jail re-entry (XOR). Contemporary clinical trials. 2016 May 10;49:57-64 (2107872)